1.
Terapevticheskii Arkhiv
; 94(2):323-323, 2022.
Article
in Russian
| Web of Science | ID: covidwho-2068330
2.
Terapevticheskii Arkhiv
; 94(2):318-318, 2022.
Article
in Russian
| Web of Science | ID: covidwho-2068047
3.
Terapevticheskii Arkhiv
; 94(2):314-314, 2022.
Article
in Russian
| Web of Science | ID: covidwho-2067848
4.
Terapevticheskii Arkhiv
; 94(2):315-315, 2022.
Article
in Russian
| Web of Science | ID: covidwho-2067847
5.
Terapevticheskii Arkhiv
; 94(2):314-315, 2022.
Article
in Russian
| Web of Science | ID: covidwho-2067846
6.
Ter Arkh
; 93(3): 343-347, 2021 Mar 15.
Article
in Russian
| MEDLINE | ID: covidwho-1200494
ABSTRACT
The SARS-CoV-2 virus enters the body through the angiotensin-converting enzyme 2 (ACE-2), which is the entry point of the virus into the cell. The most dense fabric of ACE-2 is the lungs. The small intestine also contains large amounts of ACE-2 in the enterocyte membrane and is often involved in this process. Intestinal symptoms can appear at different stages of the disease. The review describes the mechanisms of interaction of SARS-CoV-2 with enterocytes, the fecal-oral route of infection, diagnosis and treatment of COVID-19 with intestinal symptoms.